Catalyst Event
Eli Lilly and Co (LLY) · Other
From KEDI Global Longevity Bio Index (KGLB)
3/19/2026, 12:00:00 AM
Eli Lilly announced positive top-line results from its TRANSCEND-T2D-1 Phase 3 trial for retatrutide, a next-generation obesity and diabetes drug. The study showed significant reductions in both A1C levels and body weight in adults with type 2 diabetes, expected. High importance is estimated as positive Phase 3 results for a major drug typically result in a price impact exceeding 10%.
Korean Translation
일라이 릴리, 차세대 비만 및 당뇨병 치료제 레타트루타이드의 TRANSCEND-T2D-1 3상 임상시험에서 긍정적인 탑라인 결과를 발표함. 해당 연구는 제2형 당뇨병 성인 환자에서 당화혈색소(A1C) 수치와 체중 모두에서 유의미한 감소를 보임, 예상됨. 주요 약물의 긍정적인 3상 결과는 통상적으로 10% 이상의 주가 영향을 미치므로 중요도를 '높음'으로 예상함.
Related Recent Events
Biogen Inc (BIIB) · Other
U.S. FDA decision on LEQEMBI IQLIK (subcutaneous) for treatment initiation is scheduled. The FDA granted Priority Review for this supplemental Biologics License Application, with a PDUFA action date of May 24, 2026, which is expected. This event is expected to have a high price impact due to the significant market potential of the new delivery method.
5/24/2026, 12:00:00 AM
Novo Nordisk A/S (NVO) · Earnings Release
First quarter 2026 earnings release on May 6, 2026, scheduled.
5/6/2026, 12:00:00 AM
Leidos Holdings Inc (LDOS) · Earnings Release
Q1 2026 earnings release is scheduled. Impact is estimated to be low as it is a routine quarterly announcement.
5/5/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Earnings Release
Merck & Co. is expected to release its Q1 2026 earnings results on or around April 30, 2026, before the market opens. High impact expected as earnings releases often drive price movements exceeding 10%, scheduled.
4/30/2026, 12:00:00 AM
Bristol-Myers Squibb Co (BMY) · Earnings Release
Q1 2026 earnings release is scheduled.
4/30/2026, 12:00:00 AM
Teva Pharmaceutical Industries Ltd (TEVA) · Earnings Release
Teva announced it will release its financial results for the first quarter of 2026 on April 29, 2026, scheduled. Low price impact expected for this routine announcement.
4/29/2026, 12:00:00 AM